Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2001
11/01/2001US20010036453 Probiotic therapy for newborns
11/01/2001US20010036445 Method of making chewing gum containing colloidal bismuth subcitrate
11/01/2001CA2407523A1 Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same
11/01/2001CA2407493A1 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
11/01/2001CA2407449A1 Novel compounds
11/01/2001CA2407445A1 Use of 5-thio-, sulfinyl- and sulfonylpyrazolo¬3,4-b|-pyridines as cyclin dependent kinase inhibitors
11/01/2001CA2407370A1 Heterocycles that are inhibitors of impdh enzyme
11/01/2001CA2407013A1 Pharmaceutical composition promoting defecation
11/01/2001CA2407010A1 Use of recombinant gastric lipase for treating functional dyspepsia
11/01/2001CA2406949A1 Use of particulate vectors in immunomodulation
11/01/2001CA2406855A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001CA2406639A1 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001CA2406264A1 Protein phosphatases
11/01/2001CA2406067A1 Compositions comprising the combination of a bile acid and a fibrate for use in therapies for hyperlipidaemia-associated disorders
11/01/2001CA2405170A1 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
11/01/2001CA2402808A1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines
11/01/2001CA2372673A1 Cyclic amidine compounds
11/01/2001CA2365320A1 Novel heterocyclic compounds
10/2001
10/31/2001EP1149903A1 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof
10/31/2001EP1149843A1 Substituted phenethylamine derivatives
10/31/2001EP1149842A2 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
10/31/2001EP1149832A1 Benzamide derivatives and drugs containing the same
10/31/2001EP1149590A1 Use of gut peptide antibodies to improve feed efficiency
10/31/2001EP1149585A1 Use of recombinant gastric lipase for treating functional dyspepsia
10/31/2001EP1149114A2 Polypeptides involved in immune response
10/31/2001EP1149091A1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
10/31/2001EP1149090A1 Potassium salt of ($i(s))-omeprazole
10/31/2001EP1149083A1 Morpholinobenzamide salts
10/31/2001EP1149074A1 Acetylenic sulfonamide thiol tace inhibitors
10/31/2001EP1149072A1 Sulfonamide hydroxamates
10/31/2001EP1149063A2 Ureido-thiobutyric acid derivatives as ppar-agonists
10/31/2001EP1148902A1 Method of enhancing needleless transdermal powdered drug delivery
10/31/2001EP1148877A1 Methods for inhibiting bone resorption
10/31/2001EP1148791A1 Protein material for slow digestion and its use
10/31/2001EP0820455B1 5H, 10H-IMIDAZO [1,2-a]INDENO [1,2-e]PYRAZIN-4-ONE DERIVATIVES, PREPARATION THEREOF, AND DRUGS CONTAINING SAID DERIVATIVES
10/31/2001EP0737192B1 Substituted morpholine derivatives and their use as therapeutic agents
10/31/2001EP0716598B1 Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa
10/31/2001DE10021246A1 New N-substituted benzamide derivatives are tyrosine kinase KDR and FLT inhibitors useful e.g. for treating tumors, psoriasis, rheumatoid arthritis, diabetic retinopathy or liver sclerosis
10/31/2001CN1320116A Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals
10/31/2001CN1320046A Drug composition for topical administration
10/31/2001CN1320042A Seletive treatment of endothelial somatostatin receptors
10/31/2001CN1320036A Methods and compositions for treating gastro-esophageal reflux disease
10/31/2001CN1319411A Traditional Chinese medicine compound preparation for treating chronic hepatitis B and preparation process thereof
10/31/2001CN1319409A Process for preparing medicated liquid for arresting vomiting and nourishing stomach
10/31/2001CN1319407A Ganfukang pill medicine for treating hepatosis
10/31/2001CN1073996C Crystalline form of dihydro-2,3-benzodiazepine derivative
10/31/2001CN1073995C Physical form of dihydro-2,3-benzodiazepine derivative
10/31/2001CN1073852C Medicine powder for treating hepatitis A and hepatitis B
10/31/2001CN1073847C Traditional Chinese medicine for curing hepatitis
10/30/2001US6310208 Serotonin receptor binding benzo[e]isoindoles and benzo[h]isoquinolines
10/30/2001US6310181 Adaptor protein FRS2 and related products and methods
10/30/2001US6310103 Administering to a mammal suffering from urinary incontinence incontinence while reducing adverse effect associted with racemic or r-enantiiomer of tolterodine, a s(-)-2-(alpha-(2-(diisopropylamino)ethyl)benzyl)-p-cresol
10/30/2001US6310092 Treating systemic lupus, multiple sclerosis, rheumatoid arthritis, septic shock, erythema nodosum leprosy, septicemia, uveitis, adult respiratory distress syndrome or inflammatory bowel disease
10/30/2001US6310088 Treating condition associated with matrix metalloproteinases or mediated by tumor necrosis factor-alpha or enzymes involved in shedding l-selectin, cd23, tumor necrosis factor receptors, interleukin-6 receptors or interleukin-1 receptors
10/30/2001US6310077 Alkylating substituted benzofurancarboxamide with 1-chloro-3-methoxypropane in solvent in presence of base or acylating 1-(3-methoxypropyl)-4-piperidinamine with substituted benzofurancarboxylic acid, forming salt if desired
10/30/2001US6310074 Substituted dimeric compounds
10/30/2001US6310063 Aminoalkyl substituted pyrrolo [3,2-E]pyridine and pyrollo [2,3-b]pyrimidine derivatives: modulators of CRF1 receptors
10/30/2001US6310061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
10/30/2001US6309856 Human MAD proteins and uses thereof
10/30/2001US6309819 Diagnostic and therapeutic system for Crohn's disease and Colitia ulcerosa
10/30/2001US6309678 Process for isolation of hepatoprotective agent silymarin from the seeds of the plant Silybum marianum
10/30/2001US6309676 Raw garlic bonded to surface of chewable object
10/30/2001US6309663 Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
10/30/2001US6309643 Diagnosis and treatment of inflammatory bowel disease using microbial antigens.
10/30/2001CA2047843C Method and product for the treatment of gastric disease
10/28/2001CA2345569A1 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
10/25/2001WO2001083485A1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives
10/25/2001WO2001079524A2 Tissue-specific and pathogen-specific toxic agents, ribozymes, dnazymes and antisense oligonucleotides, and methods of use thereof
10/25/2001WO2001079480A1 Albumin fusion proteins
10/25/2001WO2001079468A2 Drug metabolizing enzymes
10/25/2001WO2001079444A2 Albumin fusion proteins
10/25/2001WO2001079443A2 Albumin fusion proteins
10/25/2001WO2001079442A2 Albumin fusion proteins
10/25/2001WO2001079288A2 Cytokine uses; compositions; methods
10/25/2001WO2001079282A2 Molecules associated with human reproduction
10/25/2001WO2001079278A1 Lactobacillus johnsonii bacteriocin, active against helicobacter pylori
10/25/2001WO2001079271A1 Albumin fusion proteins
10/25/2001WO2001079258A1 Albumin fusion proteins
10/25/2001WO2001079246A2 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
10/25/2001WO2001079206A1 Tricyclic quinazolinediones
10/25/2001WO2001079184A1 Substituted piperazine compounds
10/25/2001WO2001079173A2 Enamine derivatives as cell adhesion molecules
10/25/2001WO2001079156A1 Halogenated 2-amino-4, 5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/25/2001WO2001078781A2 Methods for prevention and treatment of gastrointestinal disorders
10/25/2001WO2001078779A2 Antibody alpha4beta7 integrin and its use to treat inflammatory bowel disease
10/25/2001WO2001078768A2 Targeted vaccine delivery systems
10/25/2001WO2001078757A2 Reversible immortalization
10/25/2001WO2001078754A2 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
10/25/2001WO2001078752A2 Treatment of disorders by implanting stem cells and/or progeny thereof into gastrointestinal organs
10/25/2001WO2001078720A1 Decreasing the intracellular level of beta-catenin by administering hydroxymatairesinol
10/25/2001WO2001078719A1 Halogentated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/25/2001WO2001078702A2 Methods and compositions for modulating alpha adrenergic receptor activity
10/25/2001WO2001078698A2 Use of ngf-antagonists for the prevention or treatment of chronic visceral pain
10/25/2001WO2001078654A2 Halogentated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/25/2001WO2001078533A2 Nutritional modules
10/25/2001WO2001078532A1 Composition comprising free amino acids
10/25/2001WO2001078529A2 Compositions and methods for improving vascular health
10/25/2001WO2001049288A9 Novel compounds and compositions as protease inhibitors
10/25/2001WO2001027113A3 PYRAZOLO `4,3-d! PYRIMIDINE DERIVATIVES
10/25/2001WO2001025238A3 Heterocyclic compounds useful as inhibitors of tyrosine kinases
1 ... 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 ... 1258